Deserpidine/Methyclothiazide

地舍平/甲氧噻嗪

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDeserpidine/Methyclothiazide
Drug Alias NameDeserpidine-Methyclothiazide甲氧噻嗪/地舍平Methyclothiazide/Deserpidinemethyclothiazide and deserpidineEnduronyl Forte +[6] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryUnited States
Original Approved Date1961/08/01
Country/TerritoryUnited StatesMainland China
CombinationsYes MethyclothiazideDeserpidine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbott Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Pharmaceutical Group Sanjing Pharmaceutical No. 4 Factory Co Ltd
Inactive CompaniesAbbott Laboratories
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC02LA03
Related LinksN/A